Contact details

Type of addressPostal address
Postal codeYO10 5DD
CountryUnited Kingdom
Address lines
  • Centre for Health Economics
    University of York
    Heslington
    York
    YO10 5DD

Phone: (01904) 321434

Discover related content

Find related publications, people, projects, datasets and more using interactive charts.

View graph of relations

Prof. Stephen John Palmer

Professor

  1. Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme.

    Ara, R., Duarte, A. I., Harnan, S., Leaviss, J., Palmer, S. J., Sculpher, M. & Brazier, J., 2015, Policy Research Unit in Economic Evaluation of Health and Care Interventions (EEPRU). 82 p.

    Research output: Book/ReportCommissioned report

  2. The cost-effectieveness of cognitive behavior therapy for borderline personality disorder: Results from the BOSCOT trial

    Palmer, S., Davidson, K., Tyrer, P., Gumley, A., Tata, P., Norrie, J., Murray, H. & Seivewright, H., Oct 2006

    Article in Journal of personality disorders

  3. The cost-effectiveness of an early interventional strategy in non-ST-elevation acute coronary syndrome based on the RITA 3 trial

    Henriksson, M., Epstein, D. M., Palmer, S. J., Sculpher, M. J., Clayton, T. C., Pocock, S. J., Henderson, R. A., Buxton, M. J. & Fox, K. A. A., Jun 2008

    Article in Heart

  4. The effect of disease stage on the amount of treatment received by oral cancer patients.

    Moles, D. R., Nicolau, B. F., Palmer, S., Downer, M. C. & Speight, P. M., Jun 2003

    Article in Journal of dental research

  5. The effectiveness and cost-effectiveness of biomarkers for the prioritisation of patients awaiting coronary revascularisation: a systematic review and decision model

    Hemingway, H., Henriksson, M., Chen, R., Damant, J., Fitzpatrick, N., Abrams, K., Hingorani, A., Janzon, M., Shipley, M., Feder, G., Keogh, B., Stenestrand, U., McAllister, K., Kaski, J-C., Timmis, A., Palmer, S. & Sculpher, M., Feb 2010

    Article in Health technology assessment

  6. The use of paclitaxel in the management of early stage breast cancer.

    Griffin, S., Dunn, G., Palmer, S., Macfarlane, S., Brent, S., Dyker, A., Erhorn, A., Humphries, C., White, S., Horsley, W., Ferrie, L. & Thomas, S., 2009.

    Research output: Working paper

  7. Topotecan for the treatment of recurrent and stage IVB carcinoma of the cervix

    CRD and CHE Technology Assessment Group, Paton, F. C. W., Paulden, M., Saramago, P., Manca, A., Misso, K., Palmer, S. J. & Eastwood, A. J., Apr 2009, Centre for Reviews and Dissemination/ Centre for Health Economics.

    Research output: Book/ReportCommissioned report

  8. Trastuzumab for the treatment of HER2 positive metastatic adenocarcinoma of the stomach or gastro-oesophageal junction

    CRD and CHE Technology Assessment Group, Norman, G., Rice, S. J., Spackman, E., Stirk, L., Danso-Appiah, T., Suh, D., Palmer, S. J. & Eastwood, A. J., May 2010, Centre for Reviews and Dissemination/ Centre for Health Economics.

    Research output: Book/ReportCommissioned report

  9. Uncertainty, evidence and irrecoverable costs: informing approval, pricing and research decisions for health technologies

    Claxton, K. P., Palmer, S. J., Longworth, L., Bojke, L., Griffin, S., McKenna, C., Soares, M. O., Spackman, E. & Youn, J., Oct 2011, York, UK: Centre for Health Economics, University of York, 81 p. (CHE Research Paper; no. 69).

    Research output: Working paper

  10. Using electronic health records to predict costs and outcomes in stable coronary artery disease

    Asaria, M., Walker, S. M., Palmer, S. J., Gale, C., Shah, A. D., Abrams, K., Crowther, M., Manca, A., Timmis, A., Hemingway, H. & Sculpher, M., 10 Feb 2016

    Article in Heart

Previous 1 2 3 Next